Application of biofilm-chitin oral vaccine on streptococcosis infected red hybrid tilapia (Oreochromis sp.)
Malaysia has started developing tilapia culture and has become one of the top countries in Asia. However, disease such as streptococcosis is one of the obstacles in the aquaculture industry. Two main and renowned species are Streptococcus agalactiae and Streptococ...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://psasir.upm.edu.my/id/eprint/83974/1/FP%202019%2017%20-%20ir.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Malaysia has started developing tilapia culture and has become one of the top countries in Asia.
However, disease such as streptococcosis is one of the obstacles in the aquaculture
industry. Two main and renowned species are Streptococcus agalactiae and
Streptococcus iniae. For prevention of streptococcosis, the use of antibiotics is
discouraged. Therefore, developing vaccines to prevent streptococcosis is highly
recommended. In this study, a feed-based oral biofilm-chitin vaccine was developed and tested
in red hybrid tilapia to prevent streptococcosis. For identification, the results confirmed
ten isolates of S. agalactiae and three isolates of S. iniae by API20 strep and
16SrRNA gene sequencing. This was the first report on the isolation of S. iniae from red hybrid
tilapia in Malaysia.
The virulence of S. agalactiae and S. iniae was assessed by pathogenicity. The LD50 of S.
agalactiae (MII) was determined to be 4.64 ×10⁶ CFU/ml, and S. iniae (TSK2) was 3.16
×10⁵ CFU/ml. Clinical signs of streptococcosis were observed in infected fish such
as erratic swimming, anorexia, loss of orientation, haemorrhage on the head and
eye, exophthalmia, and corneal opacity.
In this study, feed-based oral biofilm-chitin (10¹⁰ CFU/g) and feed-based oral free-cell (10¹⁰
CFU/ml) vaccines were tested to determine the antibody level of serum, mucus, and gut lavage
against S. agalactiae infection in red hybrid tilapia. In the vaccinated groups, the antibody
levels of the serum, mucus and gut lavage were significantly higher (P = 0.000) than those of the
control group.
the feed-based biofilm-chitin group for mucus (P= 0.039), serum (P = 0.042) and gut lavage (0.021) was significantly higher
than those of the feed-based free-cell and control groups.
For determining Relative Percentage Survival (RPS), the experimental groups were challenged
intraperitoneally by 0.15 mL of live virulent S. agalactiae with a concentration of 109 CFU/ml. At
14 days post-challenge, the RPS values for the feed-based biofilm-chitin, feed-based free cell and
control groups were 87, 57 and 0%, respectively. Total mortality was observed in control group due
to streptococcosis. The obtained results revealed that the survival rate in the
biofilm-vaccinated group was significantly higher (P = 0.000) than those in other
groups, which lead to high efficacy of biofilm-chitin vaccine compared with the other
groups.
At the end of the experiment, the gut samples were subjected to
histopathological test to evaluate the presence, size and number of lymphoid cells in GALT. As
a result, the GALTs in the feed-based biofilm-vaccinated group were developed with higher
intensity than those in the feed-based free- cell-vaccinated group. No GALT was observed in the
control group. In addition, the size of GALTs and the number of lymphoid cells in the feed-based
biofilm- vaccinated group were significantly higher (P = 0.000) than those in the feed- based
free-cell-vaccinated group.
In conclusion, this study revealed that the feed-based oral biofilm-chitin of S. agalactiae
stimulated the systemic and mucosal immunity in red hybrid tilapia more than feed-based free-cell
vaccine and non-vaccinated groups. Moreover, the protection of the feed-based oral biofilm-chitin
of S. agalactiae was higher against S. agalactiae infection compared with the other groups. Thus,
the feed- based oral biofilm-chitin can be a preferable candidate for dealing with S.
agalactiae infection in red hybrid tilapia due to its efficacy, low cost and ease of
usage. |
|---|